|
Monday’s hot stocks
|
 |
January 10, 2000: 2:00 p.m. ET
Aon plunges on earnings warning, but human genome research lifts Celera
|
NEW YORK (CNNfn) - An earnings warning from the world’s No. 2 insurance brokerage firm sent its shares tumbling, while advancement in human genome research lifted Celera Genomics.
Aon Corporation (AOC), plunged 27 percent after it said its fourth-quarter earnings would be between 5 and 10 cents per diluted share, far below analysts’ expectations of 58 cents.
Aon, based in Chicago, operates both brokerage and consulting operations. The stock declined 11-5/8 to 31-1/8.
Celera Genomics Group (CRA) advanced 28 percent on news of its near completion of mapping the sequence of the human genome. Celera is one of several companies involved in research of the human genome.
Rockville, Md.-based Celera gained 52-1/16 to 239.
EGlobe, Inc. (EGLO) soared 36 percent after the provider of international IP services said late Friday it will form i1.com with IDX International. The new company will provide business-to-business eCommerce solutions in China, as well as other countries in East Asia.
Washington-based eGlobe rose 3-5/16 to 12-1/2.
In the wake of merger news between Time Warner (TWX) and America Online (AOL), another merger garnered investors’ attention. Concentric Network Corporation (CNCX), a San Jose, Calif-based Internet networking provider, surged 29 percent after agreeing to merge with Nextlink Communications, Inc. (NXLK) in a $2.9 billion deal.
Concentric gained 8-5/8 to 38-5/8, but Bellevue, Wash.-based Nextlink fell 4-1/8 to 74-3/8.
Interneuron Pharmaceuticals, Inc. (IPIC) plunged 58 percent after the drug firm said Monday a preliminary trial of its stroke medication, citicoline, was not as successful as expected.
The setback follows the firm’s problems surrounding its diet drug Redux, which was withdrawn from the market in 1997.
Lexington, Mass.-based Interneuron fell 4-1/32 to 2-29/32. 
|
|
|
|
|
 |
|
